Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film

US12565617B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12565617-B2
Application numberUS-202318532334-A
CountryUS
Kind codeB2
Filing dateDec 7, 2023
Priority dateDec 8, 2022
Publication dateMar 3, 2026
Grant dateMar 3, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A polymerisable oligomeric liquid crystal (LC) and a polymerisable LC medium comprising the polymerisable oligomeric LC together with one or more mono-, di- or multireactive mesogenic compounds. Furthermore, a method for the preparation of the oligomeric LC, a birefringent polymer film obtainable from the polymerisable LC medium, and a method of preparation of such a polymer film. Also, the use of the polymer film as optical component, in particular as ultra-thin polariser (UTP) in a liquid crystal display (LCD), for contrast enhancement in an organic light emitting device (OLED), or for AR/AV/VR applications.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A polymerisable liquid crystal medium comprising one or more mono-, di- or multireactive liquid crystal or mesogenic compounds and one or more polymerisable, oligomeric liquid crystal or mesogenic compounds, wherein the at least one polymerisable oligomeric liquid crystal or mesogenic compound comprises one or more compounds of formula O: P 1 -Sp 1 -[MG 1 -X 1 -E-X 2 ] n -MG 1 -Sp 2 -P 2   O wherein P 1 and P 2 independently of each other denote a polymerisable group, Sp 1 and Sp 2 independently of each other are a spacer group or a single bond, X 1 and X 2 independently of each other denote —S—, —O— or NR x , E is alkylene having 2 to 20 C atoms, which is optionally mono- or polysubstituted by F, Cl, Br, I or CN and in which, in addition, one or more non-adjacent CH 2 groups may each be replaced, independently of one another, by —O—, —S—, —NH—, —NR x —, —SiR x R y —, —CO—, —COO—, —OCO—, —OCO—O—, —S—CO—, —CO—S—, —NR x —CO—O—, —O—CO—NR x —, —NR x —CO—NR y —, —CH═CH—or —C═C— in such a way that O and/or S atoms are not linked directly to one another, MG 1 is a rod-shaped mesogenic group, which is selected of formula M -(A 1 -Z 1 ) a -A 2 -  M wherein A 1 and A 2 denote, in case of multiple occurrence independently of one another, an aromatic or alicyclic group, which optionally contains one or more heteroatoms selected from N, O and S, and is optionally mono- or polysubstituted by L, L is P-Sp-, F, Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, —C(═O)NR x R y , —C(═O)OR x , —C(═O)R x , —NR x R y , —OH, —SF 5 , optionally substituted silyl, aryl or heteroaryl with 1 to 12 C atoms, and straight chain alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy with 1 to 12 C atoms or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy with 3 to 12 C atoms, wherein one or more H atoms are optionally replaced by F or Cl, R x and R y independently of each other denote H or alkyl with 1 to 12 C-atoms, Z 1 denotes, in case of multiple occurrence independently of one another, —O—, —S—, —CO—, —COO—, —OCO—, —S—CO—, —CO—S—, —O—COO—, —CO—NR x —, —NR x —CO—, —NR x —CO—NRY, —NR x —CO—O—, —O—CO—NR x —, —OCH 2 —, —CH 2 O—, —SCH 2 —, —CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH 2 CH 2 —, —(CH 2 ) n1 , —CF 2 CH 2 —, —CH 2 CF 2 —, —CF 2 CF 2 —, —CH═N—, —N═CH—, —N═N—, —CH═CR x —, —CY 1 =CY 2 —, —C═C—, —CH═CH—COO—, —OCO—CH═CH—or a single bond, Y 1 and Y 2 independently of each other denote H, F, Cl or CN, a is 1, 2, 3 or 4, n1 is an integer from 1 to 10, n is the average number of repeat units per molecule of compound of formula O and is from 1 to 10. 2 . The polymerisable LC medium according to claim 1 , which exhibits a smectic B phase. 3 . The polymerisable LC medium according to claim 2 , which shows a sequence nematic phase—smectic A phase—smectic B phase with decreasing temperature. 4 . The polymerisable LC medium according to claim 1 , wherein the one or more compounds of formula O comprise one or more compounds of formula O1: wherein n is the average number of repeat units per molecule of compound of formula O1 and is from 1 to 10, e is 1, 2, 3 or 4, R m is H or CH 3 , and M is selected from the following formulae: wherein L is P-Sp-, F, Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, —C(═O) NR x R y , —C(═O)OR*, —C(═O)R x , —NR x R y , —OH, —SF 5 , optionally substituted silyl, aryl or heteroaryl with 1 to 12 C atoms, and straight chain alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy with 1 to 12 C atoms or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy with 3 to 12 C atoms, wherein one or more H atoms are optionally replaced by F or Cl, r is 0, 1, 2, 3, or 4, and s is an integer from 1 to 20. 5 . The polymerisable LC medium according to claim 1 , wherein the concentration of the polymerisable oligomeric liquid crystal or mesogenic compound is from 0.05 to 15%. 6 . The polymerisable LC medium according to claim 1 , which contains one or more di- or multireactive mesogenic compounds selected from formula DRM: P 1 -Sp 1 -MG-Sp 2 -P 2   DRM wherein MG is a rod-shaped mesogenic group, which is selected of formula M -(A 1 -Z 1 ) a -A 2 -  M. 7 . The polymerisable LC medium according to claim 1 , wherein the concentration of di- or multireactive mesogenic compounds is from 5 to 70% by weight. 8 . The polymerisable LC medium according to claim 6 , comprising one or more monoreactive mesogenic compounds selected from formula MRM: P 1 -Sp 1 -MG-R  MRM wherein R denotes P-Sp-, F, Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, —C(═O)NR x R y , —C(═O)X, —C(═O)OR x , —C(═O) RY, —NR x R y , —OH, —SF 5 , optionally substituted silyl, straight chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy with 1 to 12 1 to 6 C atoms, wherein one or more H atoms are optionally replaced by F or Cl, X is halogen, and R x and R y are independently of each other H or alkyl with 1 to 12 C-atoms. 9 . The polymerisable LC medium according to claim 1 , wherein the concentration of the monoreactive mesogenic compounds is from 1 to 80% by weight. 10 . The polymerisable LC medium according to claim 1 , further comprising one or more dyes or chromophores. 11 . The polymerisable LC medium according to claim 10 , wherein the concentration of the dye(s) is from 0.1 to 10% by weight. 12 . A polymerisable oligomeric liquid crystal or mesogenic compound of formula O1: wherein n is the average number of repeat units per molecule of compound of O1 and is from 1 to 10, e is 1, 2, 3 or 4, R m is H or CH 3 , and M is selected from the following formulae: wherein L is P-Sp-, F, Cl, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, —C(═O)NR x R y , —C(═O)OR x , —C(═O)R x , —NR x R y , —OH, —SF 5 , optionally substituted silyl, aryl or heteroaryl with 1 to 12 C atoms, and straight chain alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy with 1 to 12 C atoms or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy with 3 to 12 C atoms, wherein one or more H atoms are optionally replaced by F or Cl, r is 0, 1, 2, 3, or 4, and s is an integer from 1 to 20. 13 . A process of preparing the polymerisable LC medium of claim 1 , wherein P 1 and P 2 denote an acrylate or methacrylate group, and wherein the compound of formula O is formed by the step of reacting a compound of formula MD H 2 C═CH—CO—O-Sp 1 -MG 1 -Sp 2 -O—CO—CH═CH 2   MD wherein R m denotes H or CH 3 , with a compound of formula DT HX 1 -E-X 2 H  DT in the presence of catalyst. 14 . The process of claim 13 , wherein the compound of formula MD is selected from subformula MD1 H 2 C=CR m —CO—O-M-O—CO—CR m =CH 2   MD1 wherein M is selected from formulae M-1, M-2 and M-3 and R m is H or CH 3 , wherein the compound of formula DT is selected from subformula DT1 HS—(CH 2 CH 2 O) e

Assignees

Inventors

Classifications

  • the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate · CPC title

  • Azoic · CPC title

  • Ph-COO-Ph-COO-Ph · CPC title

  • Arrangements for improving contrast, e.g. preventing reflection of ambient light · CPC title

  • Polarisers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12565617B2 cover?
A polymerisable oligomeric liquid crystal (LC) and a polymerisable LC medium comprising the polymerisable oligomeric LC together with one or more mono-, di- or multireactive mesogenic compounds. Furthermore, a method for the preparation of the oligomeric LC, a birefringent polymer film obtainable from the polymerisable LC medium, and a method of preparation of such a polymer film. Also, the use…
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/3857. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).